Eco Animal Health Group (LSE:EAH) ROCE %: 2.52% (As of Sep. 2025)


LSE:EAH Eco Animal Health Group PLC LSE:EAH
71 GF Score
Price £0.90
GF Value £1.05
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eco Animal Health Group ROCE %?

Eco Animal Health Group LSE:EAH 71 ROCE % is 2.52% as of Sep. 2025. GuruFocus rates LSE:EAH with a GF Score™ of 71/100 and a GF Value™ of £1.05 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Eco Animal Health Group's annualized ROCE % for the quarter that ended in Sep. 2025 was 2.52%.

Eco Animal Health Group  (LSE:EAH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Eco Animal Health Group ROCE % Related Terms

Eco Animal Health Group ROCE % Historical Data

* Premium members only.

The historical data trend for Eco Animal Health Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eco Animal Health Group ROCE % Chart

Eco Animal Health Group Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.06 1.74 5.23 3.79 4.53

Eco Animal Health Group Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.95 8.75 -2.24 11.45 2.52
LSE:EAH
71GF Score
Eco Animal Health Group PLC LSE:EAH
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eco Animal Health Group ROCE % Calculation

Eco Animal Health Group's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=4.461/( ( (123.265 - 25.227) + (120.603 - 21.812) )/ 2 )
=4.461/( (98.038+98.791)/ 2 )
=4.461/98.4145
=4.53 %

Eco Animal Health Group's ROCE % of for the quarter that ended in Sep. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2025 )  (Q: Mar. 2025 )(Q: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2025 )  (Q: Mar. 2025 )(Q: Sep. 2025 )
=2.472/( ( (120.603 - 21.812) + (113.956 - 16.383) )/ 2 )
=2.472/( ( 98.791 + 97.573 )/ 2 )
=2.472/98.182
=2.52 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 2.52% mean?
Eco Animal Health Group (LSE:EAH) has a ROCE % of 2.52% as of Sep. 2025.
Is Eco Animal Health Group's ROCE % too high?
Eco Animal Health Group's current ROCE % is 2.52%. The Drug Manufacturers industry median ROCE % is 7.03. Eco Animal Health Group's value of 2.52% is 64.2% below this industry median. Overall, Eco Animal Health Group has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eco Animal Health Group's ROCE % compare to ZTS and UTHR?
Eco Animal Health Group's ROCE % of 2.52% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Eco Animal Health Group's value of 2.52% is 64.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eco Animal Health Group's current ROCE % of 2.52% is 64.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eco Animal Health Group's current ROCE % is 2.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eco Animal Health Group stock overvalued right now?
Based on GuruFocus' analysis, Eco Animal Health Group (LSE:EAH) is currently considered Modestly Undervalued. The stock's GF Value™ is £1.05, compared to a current price of £0.90 — trading 14.3% below its estimated fair value. The current ROCE % is 2.52% and 64.2% below the Drug Manufacturers industry median of 7.03. Eco Animal Health Group's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Eco Animal Health Group (LSE:EAH), the current ROCE % is 2.52% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eco Animal Health Group (LSE:EAH) Overvalued in 2026?

Based on GuruFocus' analysis, Eco Animal Health Group stock appears to be undervalued. The current stock price of £0.90 is trading 14.3% below its estimated GF Value™ of £1.05. GuruFocus considers Eco Animal Health Group to be Modestly Undervalued.

Key valuation signals for LSE:EAH:

  • ROCE %: 2.52%
  • GF Value™: £1.05 vs. price of £0.90 (14.3% below fair value)
  • GF Score™: 71/100 with 5 warning signs
  • Industry Position: 64.2% below the Drug Manufacturers median

No single metric tells the full story. See the LSE:EAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eco Animal Health Group Business Description

Other Exchanges LWA:Germany
Address 100 High street, The Grange, Southgate, London, GBR, N14 6BN
Eco Animal Health Group PLC is an animal health biotech company. It provides quality products for swine and poultry, anti-infectives to treat illness, improve health, and performance. Its products include Aivlosin/Valosin Solutions and Parasite Solutions. The company's segments include Corporate/UK, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World, with the majority of the revenue deriving from China and Japan.
71GF Score

Get the complete analysis for LSE:EAH

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.90
Price
£1.05
GF Value